PL2420240T3 - Azytromycyna do leczenia trądziku guzkowego - Google Patents

Azytromycyna do leczenia trądziku guzkowego

Info

Publication number
PL2420240T3
PL2420240T3 PL11188960.6T PL11188960T PL2420240T3 PL 2420240 T3 PL2420240 T3 PL 2420240T3 PL 11188960 T PL11188960 T PL 11188960T PL 2420240 T3 PL2420240 T3 PL 2420240T3
Authority
PL
Poland
Prior art keywords
azithromycin
treatment
nodular acne
acne
nodular
Prior art date
Application number
PL11188960.6T
Other languages
English (en)
Polish (pl)
Inventor
David Wade Osborne
Gordon Jay Dow
Bhaskar Chaudhuri
Barry Calvarese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2420240T3 publication Critical patent/PL2420240T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
PL11188960.6T 2006-10-03 2007-09-24 Azytromycyna do leczenia trądziku guzkowego PL2420240T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne

Publications (1)

Publication Number Publication Date
PL2420240T3 true PL2420240T3 (pl) 2016-10-31

Family

ID=39261797

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07838730T PL2086552T3 (pl) 2006-10-03 2007-09-24 Azytromycyna do leczenia trądzika guzkowatego
PL11188960.6T PL2420240T3 (pl) 2006-10-03 2007-09-24 Azytromycyna do leczenia trądziku guzkowego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL07838730T PL2086552T3 (pl) 2006-10-03 2007-09-24 Azytromycyna do leczenia trądzika guzkowatego

Country Status (18)

Country Link
US (2) US7704959B2 (OSRAM)
EP (2) EP2086552B1 (OSRAM)
JP (1) JP2010505827A (OSRAM)
KR (1) KR20090064592A (OSRAM)
CN (2) CN101534837B (OSRAM)
AT (1) ATE533496T1 (OSRAM)
AU (1) AU2007302663B2 (OSRAM)
BR (1) BRPI0719535A2 (OSRAM)
CA (1) CA2664673A1 (OSRAM)
CY (1) CY1112650T1 (OSRAM)
DK (1) DK2086552T3 (OSRAM)
ES (2) ES2574677T3 (OSRAM)
MX (1) MX2009003484A (OSRAM)
PL (2) PL2086552T3 (OSRAM)
PT (1) PT2086552E (OSRAM)
RU (1) RU2009116629A (OSRAM)
SI (1) SI2086552T1 (OSRAM)
WO (1) WO2008042139A2 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
CN111343991A (zh) * 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
WO2002080932A1 (en) * 2001-04-05 2002-10-17 Collagenex Pharmaceuticals, Inc. Methods of treating acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Also Published As

Publication number Publication date
DK2086552T3 (da) 2012-01-09
BRPI0719535A2 (pt) 2014-01-14
AU2007302663B2 (en) 2012-07-12
WO2008042139A3 (en) 2008-10-16
CN101534837B (zh) 2012-04-04
EP2086552A2 (en) 2009-08-12
EP2086552B1 (en) 2011-11-16
EP2086552A4 (en) 2009-11-04
SI2086552T1 (sl) 2012-01-31
WO2008042139A2 (en) 2008-04-10
HK1130667A1 (en) 2010-01-08
KR20090064592A (ko) 2009-06-19
AU2007302663A1 (en) 2008-04-10
CN102614210A (zh) 2012-08-01
US20100216732A1 (en) 2010-08-26
PL2086552T3 (pl) 2012-03-30
CA2664673A1 (en) 2008-04-10
MX2009003484A (es) 2009-10-26
JP2010505827A (ja) 2010-02-25
US7704959B2 (en) 2010-04-27
US20080081790A1 (en) 2008-04-03
PT2086552E (pt) 2011-12-19
RU2009116629A (ru) 2010-11-10
EP2420240A1 (en) 2012-02-22
ES2377470T3 (es) 2012-03-27
ES2574677T3 (es) 2016-06-21
EP2420240B1 (en) 2016-05-11
CN101534837A (zh) 2009-09-16
CY1112650T1 (el) 2016-02-10
ATE533496T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
NO2018023I1 (OSRAM)
PT2368550E (pt) Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios
WO2007145862A3 (en) Extending survival of cancer patients with elevated levels of egf or tgf-alpha
ZA200706010B (en) 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-hetero-ayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
WO2007095638A3 (en) Boron-containing small molecules as anti-inflammatory agents
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
WO2008070743A3 (en) Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35
MX2010008226A (es) Derivados de difluorobifenilamida para el tratamiento de hipertension ocular.
EP2086552A4 (en) AZITHROMYCIN FOR THE TREATMENT OF NODULAR ACNE
WO2006135789A3 (en) Fiber-coupled single photon source
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
IL229594A0 (en) Materials and preparations for the treatment of tumors
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
WO2010149688A3 (en) Antitumoral compounds
ZA200706151B (en) Adapalene for the long-term treatment of acne vulgaris
DE602006005190D1 (de) Beleuchtungsvorrichtung mit reduziertem Platzbedarf
WO2007127908A3 (en) Dihydrobenzoquinone compounds
WO2007044679A3 (en) Treating metabolic syndrome with 2-deoxy-d-glucose
GB0620005D0 (en) Compounds
LT2004047A (en) A stomach band
UA29550U (en) Compound 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)-5-bromouracil with potential physiological properties
UA34805U (ru) Способ профилактики рецидивов параноидной шизофрении